MIURon™

MIURon™

(2024’ Clinical Trial scheduled)
3D nerve cellular therapeutic agent consisted of homozygous induced pluripotent stem cells

MIURon™ is a cell therapy product based on nerve cells derived from homozygous induced pluripotent stem cells,
developed specifically for the treatment of spinal injury.